Showing results (51-60 of 112) with videos related to
Sort By:
Pageof 12
JACC. Cardiovascular Interventions|June 24, 2017
Long-Term Clinical Outcomes of Patients Treated With Everolimus-Eluting Bioresorbable Stents in Routine Practice: 2-Year Results of the ISAR-ABSORB RegistryJens Wiebe, Petra Hoppmann, Roisin Colleran, et al.Journal of the American Heart Association|January 7, 2021
Early Aspirin Discontinuation After Coronary Stenting: A Systematic Review and Meta-AnalysisJens Wiebe, Gjin Ndrepepa, Sebastian Kufner, et al.Heart and Vessels|December 23, 2016
Overlapping implantation of bioresorbable novolimus-eluting scaffolds: an observational optical coherence tomography studyFlorian Blachutzik, Niklas Boeder, Jens Wiebe, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 26, 2014
Percutaneous mitral valve repair with the MitraClip system according to the predicted risk by the logistic EuroSCORE: preliminary results from the German Transcatheter Mitral Valve Interventions (TRAMI) RegistryJens Wiebe, Jennifer Franke, Edith Lubos, et al.Circulation. Cardiovascular Interventions|August 12, 2016
Intraindividual Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Drug-Eluting Metallic StentsSalvatore Cassese, Petra Hoppmann, Sebastian Kufner, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 18, 2021
A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (ISAR-DESIRE 3A)Sebastian Kufner, Himanshu Rai, Jens Wiebe, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 27, 2020
Angiographic performance of everolimus-eluting stents for the treatment of coronary in-stent restenosis in daily practiceJens Wiebe, Himanshu Rai, Constantin Kuna, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 7, 2018
A multicenter post-marketing evaluation of the Elixir DESolve<sup>®</sup> Novolimus-eluting bioresorbable coronary scaffold system: First results from the DESolve PMCF studyHolger Nef, Jens Wiebe, Niklas Boeder, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 3, 2025
Diabetes-related ten-year outcomes after percutaneous coronary intervention of in-stent restenosisConstantin Kuna, Eduard Braun, Christian Bradaric, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 19, 2020
Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantationJens Wiebe, Felix J Hofmann, Oliver Dörr, et al.Pageof 12